BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17088172)

  • 1. Psychotropic discontinuation symptoms: a case of withdrawal neuroleptic malignant syndrome.
    Stonecipher A; Galang R; Black J
    Gen Hosp Psychiatry; 2006; 28(6):541-3. PubMed ID: 17088172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
    Margetić B; Aukst-Margetić B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome without neuroleptics.
    Ong KC; Chew EL; Ong YY
    Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroleptic malignant syndrome with clozapine monotherapy and benign hyperthermia after resolving neuroleptic malignant syndrome with clozapine. Two case reports].
    Vetter P; Proppe D; Hoppe-Seyler S
    Nervenarzt; 1991 Jan; 62(1):55-7. PubMed ID: 2027422
    [No Abstract]   [Full Text] [Related]  

  • 5. Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance.
    Ladha SS; Walker R; Shill HA
    Mov Disord; 2005 May; 20(5):630-1. PubMed ID: 15719433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential adverse effects of discontinuing psychotropic drugs. Part 3: Antipsychotic, dopaminergic, and mood-stabilizing drugs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Aug; 48(8):11-4. PubMed ID: 20669865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential adverse effects of discontinuing psychotropic drugs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Sep; 48(9):11-4. PubMed ID: 20795589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling.
    Einarson A; Selby P; Koren G
    J Psychiatry Neurosci; 2001 Jan; 26(1):44-8. PubMed ID: 11212593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome associated with bromocriptine withdrawal in Parkinson's disease--a case report.
    Wu YF; Kan YS; Yang CH
    Gen Hosp Psychiatry; 2011; 33(3):301.e7-8. PubMed ID: 21601731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome-like reaction precipitated by antipsychotics in a patient with gamma-butyrolactone withdrawal.
    Eiden C; Capdevielle D; Deddouche C; Boulenger JP; Blayac JP; Peyrière H
    J Addict Med; 2011 Dec; 5(4):302-3. PubMed ID: 21817917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic agents: a review.
    Dilsaver SC
    Am Fam Physician; 1993 Jan; 47(1):199-204. PubMed ID: 8418582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared features of neuroleptic malignant syndrome and alcohol abuse complications.
    Krystal AD; McEvoy JP
    J Clin Psychiatry; 1990 Dec; 51(12):523. PubMed ID: 2258367
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of neuroleptic malignant syndrome caused by discontinuation of psychotropic drugs].
    Takahashi Y; Yaguchi M; Yaguchi H; Togashi A; Suzuki M
    Rinsho Shinkeigaku; 2022 Nov; 62(11):850-855. PubMed ID: 36288965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The neuroleptic malignant syndrome].
    Duarte J; García Viejo MA; García Miguel FJ; Sempere AP
    Med Clin (Barc); 1994 Oct; 103(14):558. PubMed ID: 7799673
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential adverse effects of discontinuing psychotropic drugs. Part 1: Adrenergic, cholinergic, and histamine drugs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Jun; 48(6):11-4. PubMed ID: 20506969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric iatrogenic disorders.
    Siomopoulos V
    Am Fam Physician; 1986 Oct; 34(4):111-6. PubMed ID: 3766357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Illicit drugs of abuse.
    Schulz JE
    Prim Care; 1993 Mar; 20(1):221-30. PubMed ID: 8464943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Withdrawal in newborns after exposure to psychotropic medications during pregnancy].
    Kieviet N; Dolman K; Wennink H; Heres M; Honig A
    Ned Tijdschr Geneeskd; 2012; 156(16):A4395. PubMed ID: 22510415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etiologic mechanism of neuroleptic malignant syndrome--hypothesis of dopamine-serotonin imbalance].
    Yamawaki N
    Seishin Shinkeigaku Zasshi; 1988; 90(10):869-76. PubMed ID: 3251270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.